B-SAFE, détecteur électronique connecté de substances dans les boissons contre la soumission chimique

B-SAFE: French drink drug detection innovation

French innovation · Protected technology

B-SAFE: a new generation of detection in beverages

B-SAFE is a connected electronic detector developed by LUEUR and officially distributed by AMA Prévention. It helps professionals quickly analyze a suspicious beverage, obtain an indication via a mobile interface and promptly initiate a safety protocol.

30+substances and families targeted according to the manufacturer's documentation
< 30 sto obtain a rapid indication depending on the conditions of use
5 000possible measurements announced for repeated professional use
7patent applications at the INPI highlighted by LUEUR
Beyond the disposable test

A connected, reusable electronic device

B-SAFE is not limited to a color change on a single-use medium. The device combines a miniaturized sensor, electronic reading and a mobile interface that provides more details about the indication obtained.

This architecture is designed for bars, clubs, festivals, student unions, local authorities, public-access establishments, security teams, first-aid posts and prevention professionals who need to manage a suspicion in a real-world environment: low light, large crowds and the need to act quickly.

B-SAFE, a connected electronic detector for substances in beverages
Pen format, fast reading and associated mobile interface.
Key features

What really sets B-SAFE apart

01

Electronic reading

The result does not rely solely on a visual assessment. The device provides an indication intended to help the team respond.

02

Mobile application

Connecting to the mobile interface makes it possible to refine the reading and obtain the available details about the type or family of substance detected.

03

Evolving technology

Service and device updates make it possible to expand the information available and, subject to the manufacturer's validations, the range covered.

04

French ecosystem

Developed and manufactured in France, with support, technical assistance and after-sales service based in France.

7
Research and industrial property

Seven patent applications to protect the technology

LUEUR's documentation highlights 7 patent applications filed with the INPI. This industrial property strategy reflects the scale of the research conducted around the sensor, miniaturization, analysis and connected ecosystem.

A patent application protects an invention or a family of innovations; on its own, it does not replace performance testing or the conditions of use communicated by the manufacturer.

Scientific support

Professor Jean-Claude Alvarez involved in the scientific development

In the project documentation, LUEUR states that B-SAFE benefits from the support of Professor Jean-Claude Alvarez, a professor of pharmacology and toxicology and a recognized specialist in analytical and forensic toxicology in Garches.

This expertise helps provide a scientific framework for development and performance interpretation. However, B-SAFE remains a prevention and decision-support tool: it does not replace a medical diagnosis, official toxicological analysis or forensic evidence.

Field use

How does B-SAFE work?

1

Collect

Dip the designated end into the suspected drink in accordance with the manufacturer's protocol.

2

Analyze

The device takes its measurement and provides an initial indication within a few seconds.

3

Interpret

The mobile interface complements the reading with the available detection information.

4

Protect

Isolate the drink, ensure the person's safety and immediately apply the facility's protocol.

Detection spectrum

A multi-substance approach, not just anti-GHB

Chemical submission may involve various sedative, medicinal or psychoactive substances. B-SAFE is presented as a broad-spectrum detector, targeting more than 30 substances or families depending on the version and the manufacturer's data.

GHB and sedative substancesTargeted screening for suspected drink situations.
BenzodiazepinesIncluding in particular flunitrazepam, known as Rohypnol®.
Other familiesOpioids, sedating antihistamines, MDMA and other substances indicated by the manufacturer.
Updated through software releasesThe range of substances covered and the information displayed may expand with validated system versions.
Responsible interpretation. A negative indication does not rule out all possible substances. A reactive indication does not constitute a medical diagnosis. The person's symptoms and safety remain the priority.
Professional deployment

A tool designed to structure team responses

Bars and clubs

Set up an identified control point and train a designated team.

Festivals and events

Equip prevention, security, or first-aid stations.

Student unions and associations

Strengthen student events with a written, clearly visible procedure.

Local authorities and public venues

Integrate B-SAFE into a broader public protection policy.

If you suspect something

The test never replaces ensuring the person's safety

  1. Do not leave the person alone and move them away from danger.
  2. Stop consuming and keep the drink if this can be done safely.
  3. Immediately notify management, security, or the first-aid station.
  4. Call 15 or 112 in case of drowsiness, confusion, loss of consciousness, or difficulty breathing.
Frequently asked questions

Key answers

Does B-SAFE detect only GHB?

No. B-SAFE is presented as a multi-substance solution covering more than 30 substances or families, depending on the documentation and system version.

Why is the mobile application important?

The device provides a rapid indication. The mobile interface offers an additional level of interpretation of the available information about the type or family of substance detected.

What do the seven patents cover?

LUEUR states that it has filed seven patents with the INPI relating to the technology. They protect innovative elements; they do not replace testing or the device's usage limitations.

Does B-SAFE replace laboratory analysis?

No. B-SAFE is a prevention and decision-support tool. Only samples and analyses carried out in a medical or forensic setting can provide official confirmation.

Who is B-SAFE for?

Primarily for professionals and organizers: bars, clubs, festivals, student unions, local authorities, public venues, security teams, and prevention stakeholders.

AMA Prévention support

Integrate B-SAFE into a professional protocol

AMA Prévention, LUEUR's official distributor, supports organizations with onboarding, deployment, team awareness, updates, and assistance.

Editorial transparency

Sources and verification method

Writing and documentary review: AMA Prévention editorial team. Last revised: July 24, 2026.

Accuracy: the performance, speed, coverage, and patent data cited in this article come from the manufacturer's documentation. The AP-HP page attests to the functions and expertise of Professor Jean-Claude Alvarez; it does not constitute certification of B-SAFE's performance.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.